Bookmark and Share
LAP3 (geneid:51056) - Gene BioActivity Data
Also known as: HEL-S-106, LAP, LAPEP, PEPS.
BioActivity Outcomes:
Active(27)
 
 
Inactive(49)
 
 
Inconclusive(1)
 
 
Unspecified(2)
 
 
BioAssay Types:
Confirmatory(69)
 
 
 
Literature(10)
 
 
 
 
 
BioActivity Types:
IC50(70)
 
 
 
Substance Types:
Chemical(72)
 
 
 
 
RNAi(7)
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 9    Data Row: 79   Total Pages: 2   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID125311608]
[CID53315822]
Average HUM17LAP IC50 0.21Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
2
[SID125311595]
[CID53384804]
Average HUM17LAP IC50 0.28Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
3
[SID104233677]
[CID24689999]
Average HUM17LAP IC50 0.29Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
4
[SID93577810]
[CID2466]
Average HUM17LAP IC50 0.31Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
5
[SID125311594]
[CID53315819]
Average HUM17LAP IC50 0.35Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
6
[SID131485166]
[CID54758532]
Average HUM17LAP IC50 0.38Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory] [gi:4335941]
View
7
[SID131485162]
[CID25922]
Average HUM17LAP IC50 0.49Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory] [gi:4335941]
View
8
[SID125311591]
[CID53315818]
Average HUM17LAP IC50 0.52Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
9
[SID131485172]
[CID53315831]
Average HUM17LAP IC50 0.53Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory] [gi:4335941]
View
10
[SID104233678]
[CID289794]
Average HUM17LAP IC50 0.99Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
11
[SID125311590]
[CID4589721]
Average HUM17LAP IC50 1.11Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
12
[SID125311588]
[CID14545018]
Average HUM17LAP IC50 1.18Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
13
[SID125311597]
[CID12814959]
Average HUM17LAP IC50 1.64Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
14
[SID125311598]
[CID23380591]
Average HUM17LAP IC50 1.82Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
15
[SID131485168]
[CID54758533]
Average HUM17LAP IC50 2.77Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory] [gi:4335941]
View
16
[SID125311593]
[CID53384800]
Average HUM17LAP IC50 4.58Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
17
[SID125311596]
[CID142752]
Average HUM17LAP IC50 8.23Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
18
[SID131485169]
[CID25164]
Average HUM17LAP IC50 8.38Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory] [gi:4335941]
View
19
[SID125311599]
[CID10171341]
Average HUM17LAP IC50 8.67Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
20
[SID103201243]
[CID72172]
IC50 11.2Inhibitory concentration against adipocyte-derived leucine aminopeptidase [AID241862, Type: Literature] [gi:124028615]
View
21
[SID125311589]
[CID53384801]
Average HUM17LAP IC50 16.19Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
22
[SID110722949]
[CID14147704]
Average HUM17LAP IC50 19.99Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
23
[SID125311601]
[CID23382]
Average HUM17LAP IC50 31.92Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
24
[SID104233657]
[CID49859552]
Average HUM17LAP IC50 44.25Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
25
[SID104233666]
[CID17377721]
Average HUM17LAP IC50 85.73Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
26
[SID131485171]
[CID21494912]
Average HUM17LAP IC50 114.27Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory] [gi:4335941]
View
27
[SID160739931]
Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Ambion Library) [AID651811, Type: Literature] [geneid:51056]
View
28
[SID85103046]
siRNA Circadian Assay [AID1904, Type: Literature] [geneid:51056]
View
29
[SID85110269]
siRNA Circadian Assay [AID1904, Type: Literature] [geneid:51056]
View
30
[SID103447225]
[CID11436221]
Inhibitory concentration against adipocyte-derived leucine aminopeptidase; NA = Not active [AID242227, Type: Literature] [gi:124028615]
View
31
[SID110722950]
[CID667595]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
32
[SID104233656]
[CID2826349]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
33
[SID104233679]
[CID4192200]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
34
[SID104233680]
[CID17019804]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
35
[SID104233681]
[CID17378814]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
36
[SID104233682]
[CID839551]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
37
[SID104233683]
[CID977924]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
38
[SID110722947]
[CID3080766]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
39
[SID110722948]
[CID151275]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
40
[SID104233667]
[CID805387]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
41
[SID104233668]
[CID687334]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
42
[SID104233669]
[CID3914034]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
43
[SID104233670]
[CID1299166]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
44
[SID104233672]
[CID2224947]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
45
[SID104233673]
[CID2385866]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
46
[SID104233674]
[CID781370]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
47
[SID104233675]
[CID24237873]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
48
[SID104233676]
[CID2362078]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
49
[SID104233658]
[CID853791]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View
50
[SID104233659]
[CID1011051]
Average HUM17LAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602214, Type: confirmatory] [gi:4335941]
View